Philips expects sales struggles in China to continue in 2025

medtechdive.com

Center

Factuality

Ownership

Philips expects sales struggles in China to continue in 2025

Philips forecast a double-digit sales decline in China for the first half of 2025 after reporting “significant deterioration” of demand in October.

Consenso del Mercado

Factuality

Ownership

Consensus of the Singular Market Bank The Dutch healthcare multinational has had an income in the 4Q24 annual plans, although with organic growth of 1.4%. The margin achieved has been 60 p.b. greater up to 13.5%, but the net profit ended in losses of 334 million, especially due to the weak situation in China. The entry of comparable orders increased 2% in the last quarter and the profitability per dividend stands at 3.75%. The share has risen 1…

eeNews Europe

Factuality

Ownership

Philips tackles China tariffs hit with €800m cuts

Philips sees a flat business in 2025 as it recovers from a damaging recall and coming tariffs in China with €800m of cuts. The company is going through a three year restructuring, “within a challenging macro environment”, that includes selling off its MEMS foundry business in Eindhoven. The company is now raising its productivity savings […] The post Philips tackles China tariffs hit with €800m cuts appeared first on eeNews Europe.

Moneycab

Factuality

Ownership

The medical technology group Philips continues to struggle with weak sales. Above all, the persistently difficult China business is burdening Siemens Healthineers' competitors.